US Drug Recall Register
Class III · Low risk Terminated Initiated Nov 10, 2015 (11 years ago)

Prednisone 20 mg

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Labeling: Not elsewhere classified. NDC number is incorrect on the container.

What was recalled

Prednisone 20 mg, Tablet, 10-count bottle, Rx only, Mfg by: HIKMA Pharmaceuticals PO BOX 182400 Amman 11118 Jordan. Dist By: West-Ward Pharmaceuticals Corp., Eatentown, NJ 07724 USA, Repackaged By: Northwind Pharmaceuticals, Indianapolis, IN 46256. NDC 51655-320-53

Recalling firm
Northwind Pharmaceuticals LLC
NDC code
51655-320-53
Origin
IN, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0485-2016

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Prednisone recalls

See all
Class II · Moderate risk Terminated

Prednisone Tablets USP

Reason Presence of foreign tablet: 2.5 mg tablet in a 20 mg bottle of Prednisone Tablets

Strides Pharma Inc. NDC 64380-785-06 D-1330-2022
Class II · Moderate risk Terminated

PredniSONE Tablets

Reason CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.

Cardinal Healthcare D-0193-2024
Class II · Moderate risk Terminated

Prednisone Tablets

Reason Labeling: Label Mix Up: bottle labeled to contain Prednisone Tablets, USP 2.5 mg actually contained Prednisone Tablets, USP 10 mg

Lannett Company, Inc. NDC 0527-2931-37 D-1508-2020
Class II · Moderate risk Terminated

PredniSONE Tablets USP

Reason Failed Tablet/Capsule Specifications: Discovery of an underweight tablet.

West-Ward Pharmaceutical NDC 0054-4741-25 D-0008-2017
Class II · Moderate risk Terminated

Prednisone active pharmaceutical ingredient packaged in varying…

Reason Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Attix Pharmaceuticals D-858-2015